Advanced Filters
noise
Found 61,726 clinical trials
H Harleen K Sandhu, MD, MPH

ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy

The purpose of the study is to conduct a randomized controlled trial comparing best medical therapy (BMT) alone to BMT with thoracic endovascular aortic repair (BMT+TEVAR) for uncomplicated acute type B aortic dissection.

18 years of age All Phase N/A
J Jonathan D Schoenfeld, MD, MPH

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

This research is being conducted to understand if treatment can be tailored for participants with HPV-related oropharynx cancers using both clinical features (stage of the tumor, smoking status) combined with an investigational HPV blood test. The names of the test and treatments involved in this study are: NavDx® HPV ctDNA …

22 years of age All Phase 2
P Pia Karlsland-Akeson, MD, PhD

Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula

Breastfeeding is the recommended diet for all infants during the first half of infancy and is associated with numerous health benefits. However, when breastfeeding is not possible, an infant formula is the only nutritive alternative. Formula-fed infants have a different growth pattern compared to breastfed infants. Studies have shown that …

4 - 8 years of age All Phase N/A

Oxygen Wound Therapy Feasibility Study

Determine the feasibility of using a new topical oxygen therapy device to treat hard to heal lower leg wounds.

16 years of age All Phase N/A

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

This study will investigate the safety and efficacy of using robotic retroperitoneal lymph node dissection (R-RPLND), a minimally invasive surgical approach, as the first-line of treatment for stage IIA/B (or equivalent) seminoma patients. R-RPLND will be trialed as an alternative to chemotherapy, radiation therapy (for seminoma patients) and open RPLND …

18 years of age Male Phase N/A
Y Ying Cheng, Bachelor

Efficacy and Safety of IBI351 in Combination With Sintilimab ± Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

This Phase Ib/III study evaluates the efficacy and safety of IBI351 in combination with Sintilimab± chemotherapy in advanced non-squamous NSCLC with KRAS G12C mutation.

18 - 75 years of age All Phase 1
A Ali Hosni, MD

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

The proposed study is a phase II, single arm, open-label trial of MR-guided radiation therapy (RT) with risk stratified RT dose selection in patients with anal cancer. Based on previous data, a risk adaptive treatment approached is proposed in 4 groups: Low risk, standard risk, intermediate risk, and high risk. …

18 years of age All Phase 2
E Edouard Louis, MD

MSC Intratissular Injection in Crohn Disease Patients

The main objective is to assess the efficacy of local injection of MSC on the healing of refractory intestinal and perianal lesions in crohn disease. The second co-primary endpoint is safety.

18 years of age All Phase 1/2

A Register Based Prospective Study During Implementation of a New Cup

In a prospective register-based study, we aim to evaluate the implant survival, clinical outcomes and X-ray findings by following a cohort of patients operated with the Trident II cup.

30 - 75 years of age All Phase N/A

Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

This is a randomized clinical trial that randomizes between treatment principles. The study will investigate if precision therapy determined by a tumour board is better than standard treatment for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) in elderly. The tumour board will decide the precision therapy based on identified …

60 years of age All Phase 2

Simplify language using AI